BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15067003)

  • 1. Activation of skeletal ryanodine receptors by two novel scorpion toxins from Buthotus judaicus.
    Zhu X; Zamudio FZ; Olbinski BA; Possani LD; Valdivia HH
    J Biol Chem; 2004 Jun; 279(25):26588-96. PubMed ID: 15067003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide probe of ryanodine receptor function. Imperatoxin A, a peptide from the venom of the scorpion Pandinus imperator, selectively activates skeletal-type ryanodine receptor isoforms.
    el-Hayek R; Lokuta AJ; Arévalo C; Valdivia HH
    J Biol Chem; 1995 Dec; 270(48):28696-704. PubMed ID: 7499390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of inhibition of ryanodine receptor channels by imperatoxin I, a heterodimeric protein from the scorpion Pandinus imperator.
    Zamudio FZ; Conde R; Arévalo C; Becerril B; Martin BM; Valdivia HH; Possani LD
    J Biol Chem; 1997 May; 272(18):11886-94. PubMed ID: 9115249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant expression of Intrepicalcin from the scorpion Vaejovis intrepidus and its effect on skeletal ryanodine receptors.
    Vargas-Jaimes L; Xiao L; Zhang J; Possani LD; Valdivia HH; Quintero-Hernández V
    Biochim Biophys Acta Gen Subj; 2017 Apr; 1861(4):936-946. PubMed ID: 28159581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hadrucalcin, a peptide from Hadrurus gertschi scorpion venom with pharmacological activity on ryanodine receptors.
    Schwartz EF; Capes EM; Diego-García E; Zamudio FZ; Fuentes O; Possani LD; Valdivia HH
    Br J Pharmacol; 2009 Jun; 157(3):392-403. PubMed ID: 19389159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the high-affinity activation of type 1 ryanodine receptors by imperatoxin A.
    Lee CW; Lee EH; Takeuchi K; Takahashi H; Shimada I; Sato K; Shin SY; Kim DH; Kim JI
    Biochem J; 2004 Jan; 377(Pt 2):385-94. PubMed ID: 14535845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism.
    Chen L; Estève E; Sabatier JM; Ronjat M; De Waard M; Allen PD; Pessah IN
    J Biol Chem; 2003 May; 278(18):16095-106. PubMed ID: 12586831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the ryanodine receptor Ca2+ release channel of sarcoplasmic reticulum by a novel scorpion venom.
    Valdivia HH; Fuentes O; el-Hayek R; Morrissette J; Coronado R
    J Biol Chem; 1991 Oct; 266(29):19135-8. PubMed ID: 1655775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of ryanodine receptors by imperatoxin A and a peptide segment of the II-III loop of the dihydropyridine receptor.
    Gurrola GB; Arévalo C; Sreekumar R; Lokuta AJ; Walker JW; Valdivia HH
    J Biol Chem; 1999 Mar; 274(12):7879-86. PubMed ID: 10075681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imperatoxin A (IpTx(a)) from Pandinus imperator stimulates [(3)H]ryanodine binding to RyR3 channels.
    Simeoni I; Rossi D; Zhu X; García J; Valdivia HH; Sorrentino V
    FEBS Lett; 2001 Nov; 508(1):5-10. PubMed ID: 11707258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary structure and synthesis of Imperatoxin A (IpTx(a)), a peptide activator of Ca2+ release channels/ryanodine receptors.
    Zamudio FZ; Gurrola GB; Arévalo C; Sreekumar R; Walker JW; Valdivia HH; Possani LD
    FEBS Lett; 1997 Apr; 405(3):385-9. PubMed ID: 9108323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eudistomin D and penaresin derivatives as modulators of ryanodine receptor channels and sarcoplasmic reticulum Ca2+ ATPase in striated muscle.
    Diaz-Sylvester PL; Porta M; Juettner VV; Lv Y; Fleischer S; Copello JA
    Mol Pharmacol; 2014 Apr; 85(4):564-75. PubMed ID: 24423447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scorpion toxins targeted against the sarcoplasmic reticulum Ca(2+)-release channel of skeletal and cardiac muscle.
    Valdivia HH; Kirby MS; Lederer WJ; Coronado R
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12185-9. PubMed ID: 1334561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationships of peptides forming the calcin family of ryanodine receptor ligands.
    Xiao L; Gurrola GB; Zhang J; Valdivia CR; SanMartin M; Zamudio FZ; Zhang L; Possani LD; Valdivia HH
    J Gen Physiol; 2016 May; 147(5):375-94. PubMed ID: 27114612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide mimetic compounds can activate or inhibit cardiac and skeletal ryanodine receptors.
    Robinson K; Culley D; Waring S; Lamb GD; Easton C; Casarotto MG; Dulhunty AF
    Life Sci; 2020 Nov; 260():118234. PubMed ID: 32791148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitochondrial ryanodine receptor in rat heart: a pharmaco-kinetic profile.
    Altschafl BA; Beutner G; Sharma VK; Sheu SS; Valdivia HH
    Biochim Biophys Acta; 2007 Jul; 1768(7):1784-95. PubMed ID: 17499575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ryanoids and imperatoxin affect the modulation of cardiac ryanodine receptors by dihydropyridine receptor Peptide A.
    Porta M; Diaz-Sylvester PL; Nani A; Ramos-Franco J; Copello JA
    Biochim Biophys Acta; 2008 Nov; 1778(11):2469-79. PubMed ID: 18722342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional location of the imperatoxin A binding site on the ryanodine receptor.
    Samsó M; Trujillo R; Gurrola GB; Valdivia HH; Wagenknecht T
    J Cell Biol; 1999 Jul; 146(2):493-9. PubMed ID: 10427100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of an alpha-toxin Bs-Tx28 from scorpion (Buthus sindicus) venom suggests a new alpha-toxin subfamily.
    Ali SA; Wang B; Alam M; Beck A; Stoeva S; Voelter W; Abbasi A; Duszenko M
    Arch Biochem Biophys; 2006 Jan; 445(1):81-94. PubMed ID: 16309623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells.
    Estève E; Smida-Rezgui S; Sarkozi S; Szegedi C; Regaya I; Chen L; Altafaj X; Rochat H; Allen P; Pessah IN; Marty I; Sabatier JM; Jona I; De Waard M; Ronjat M
    J Biol Chem; 2003 Sep; 278(39):37822-31. PubMed ID: 12869557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.